IMT Feedback

    Did the IMT help you in finding the resource you needed?

    Your feedback helps us improve the toolkit in the future.

    Are you experiencing difficulties? Please include information on your search query and used browser



    Input this code: captcha

    Skip to content
    • Homepage
    • Browse Resources
    • Questions
    • Use Cases
    • Collections
      • Clinical Trials Toolkit
      • Orphan Drug Guide
      • Mentoring packages
      • EJPRD online courses
      • EBStatMax
      • Advisory Committee for Therapeutics Toolkit
    • Services
    • My IMT
    ERDERA IMT

    Browse Resources

    Categories

    • Translational Project Management
      • Project Management
        • Clinical Trial Management
        • Data Management
        • Project Management Manual
      • TPP
      • Reverse Planning Approach
      • Technology Transfer Offices (TTO's)
        • What is technology transfer?
        • TTO and Intellectual Property Management
        • TTO and Commercialisation
      • Consulting & Advice
        • TREAT-NMD Advisory Committee for Therapeutics (TACT)
    • Research and Drug Development
      • Disease Model
        • In Silico Model
        • Cell Model
        • Animal Model
      • Disease or Translational Resources
        • Patients Registries
        • Natural History
        • Patients Information
        • Target Patient Value Profile
        • Data Bases or Tools
        • Networks
        • Biobanks
        • Biomarkers
      • Drug Discovery
        • Small Molecules
        • Advanced Therapies
        • Target Validation
        • High Throughput Screening (HTS)
        • Bioassays
        • Drug Repurposing
      • Data Collection
        • Patient Registries
      • Clinical Development
        • Safety Reporting
        • Dissemination
        • Clinical Trial Design
        • Endpoints
        • Patients
    • Regulatory Science
      • Preclinical Studies
        • Animal Model
        • Safety
        • Efficacy
      • Early Acces Support
        • Orphan Drug Designation
        • Orphan Drug or Medical Device Designation
        • Scientific Advice
        • SME Office
        • Patient Advice
        • Scientific Guidelines
        • Orphan Medicines
        • Nan-byo Designation
        • Paediatric Medicines
        • Advanced Therapy
      • Biological
      • Clinical Development
        • Good Clinical Practices
        • Compassionate Use
      • Marketing Authorisation
        • Marketing Authorisation Road Map
        • Advanced Therapy procedure
        • Conditional Approval
        • Exceptional Circumstances
        • FDA Priority Review Voucher
      • Ethic and Legal Issues
        • Data protection and confidentiality
        • Clinical Studies
        • Clinical Trials
        • Orphan medicines
        • Genetics
        • Paediatrics
        • Advanced Therapies
        • Biomarkers
        • Animal Welfare
      • HTA
        • National HTA Bodies
        • European HTA Bodies
        • International HTA Bodies
    • Funding Sources
      • Public Funding Sources
        • Awards
        • Fellowships
        • Accelerators or Incubators
        • Grant
        • Loans
      • Private Funding Sources
        • Crowdfunding
        • Venture Capital or Angel Investment
        • Foundations
        • Awards
        • Fellowships
        • Accelerators or Incubators
        • Grant
        • Loans
    • Intellectual Property
      • Basics of Intellectual Property
        • Types of Intellectual Property
        • Intellectual Property Teaching Kit
        • Freedom to Operate (FTO)
      • Patent Filing
        • International Patent Cooperation Treaty (PCT) Route
        • European Route
        • American Route
      • Patent Search
        • Patentscope
        • Espacenet
      • Market Exclusivity
        • Incentives in Orphan Medicines
        • Incentives in Paediatric Medicines
      • Commercialisation

    Subjects

    All SubjectsIntellectual PropertyIP Commercialisation

    Regions

    • All regions
      • Europe

    Commercialisation

    1. Showing 1 result for:
    2. Intellectual Property
    3. Commercialisation
    All Subjects

    Guide to IP in Europe

    Published by European Commission (EC)

    Intellectual PropertyIP Commercialisation

    The purpose of this guide is to spotlight critical aspects and novelties related to Intellectual Property (IP) management in the context of collaborative research and innovation projects funded under the European Union’s current Framework Programme for Research and Innovation “Horizon Europe” (2021-2027).

    View this resource Bookmark this resource
    The Innovation Management Toolbox was originally developed through funding from the EJP RD project, which received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 825575. The continued development and maintenance of the Toolbox are now supported by the ERDERA partnership, funded under the European Union’s Horizon Europe Research & Innovation programme, grant agreement No. 101156595.
    © 2025 ERDERA IMT | GetYos IT